Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

COVID-19 Vaccine Updates

Hear expert insights on the latest data and updates regarding COVID-19 vaccines, including fourth doses, CDC recommendations, the availability of a new, non-mRNA vaccine, and authorization for our youngest pediatric patients.
Renslow Sherer, MD
Released: August 1, 2022

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Faculty

Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Renslow Sherer, MD, has disclosed an unrestricted research grant from Gilead Sciences.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Program Medium

This program has been made available online.

Related Content

Dr Helen Chu shares how the COVID-19 pandemic has influenced RSV diagnostic and prevention efforts, from Clinical Care Options (CCO)

Helen Y. Chu, MD, MPH Released: January 31, 2023

Learn from Dr Zhuxin Mao about emerging data on quantifying quality of life of older adults with RSV, from Clinical Care Options (CCO)

person default Zhuxin Moa, PhD Released: January 30, 2023

This downloadable PDF reviews a treatment pathway for nonhospitalized patients with COVID-19, from Clinical Care Options (CCO), Practicing Clinicians Exchange (PCE), and ProCE

Renslow Sherer, MD Released: January 17, 2023

Dr Stephaun Elite Wallace on COVID-19 inequities in BIPOC communities and strategies to minimize these disparities, from Clinical Care Options (CCO), Practicing Clinicians Exchange (PCE), and ProCE

Stephaun Elite Wallace, PhD, MS Released: January 17, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings